News &amp; Updates

Children diagnosed with asthma between ages 5 and 7 years may have an increased risk of developing type 1 diabetes (T1D) and inflammatory bowel diseases (IBD; Crohn’s disease and ulcerative colitis), a Danish nationwide registry study suggests.

15 Feb 2023

Smoking may promote diabetes in middle-age, older adults

Current and former smoking among middle-age and older adults appear to increase the risk of developing type 2 diabetes (T2D), with compounds other than nicotine underlying the detrimental association between smoking and T2D, as reported in a study.

Registered doctors can still collect CPD points to renew APC 2023

The Malaysian Medical Council (MMC), at its 426th meeting on 17 January 2023, has considered the proposal from the Malaysian Medical Association (MMA), and has agreed to allow doctors with insufficient CPD points for APC 2023 attend a special course in order to obtain the minimum 20 CPD points required by 31 March 2023.

Combo therapy in IBD: Is de-escalation possible after 1 year?

Clinicians should consider de-escalating combination therapy with immunomodulators to a monotherapy after 1 year in patients with inflammatory bowel disease (IBD), says an expert at Crohn’s and Colitis Congress 2023.

Single-dose azithromycin during labour prevents maternal death, sepsis

Treatment with a single oral dose of azithromycin, given to women in labour who were planning a vaginal birth, significantly reduced the risk of maternal death or sepsis, according to the A-PLUS* trial presented at SMFM 2023.

$Aspirin as good as heparin for thromboprophylaxis in patients with fractures$

Aspirin as good as heparin for thromboprophylaxis in patients with fractures

Thromboprophylaxis with aspirin in patients with extremity fractures appears to prevent death and lower the incidences of deep-vein thrombosis and pulmonary embolism without any significant differences as compared with thromboprophylaxis with low-molecular-weight heparin, according to a study.

14 Feb 2023

Elinzanetant a promising nonhormone treatment option for VMS, sleep problems

14 Feb 2023 by

The selective neurokinin (NK)-1,3 receptor antagonist elinzanetant appears to be beneficial in the treatment of vasomotor symptoms (VMS) and associated sleep disturbance in postmenopausal women, as shown in the results of the phase IIb SWITCH-1 trial.

Risk model-based lung cancer screening more economical than USPSTF recommendation

Lung cancer screening based on a risk model is more cost-effective than the 2021 recommendation by the US Preventive Services Task Force (USPSTF), meriting further consideration for the former, reports a recent study.

14 Feb 2023

Statins reduce MACE in patients with normal MPI, elevated CAC score

14 Feb 2023 by

Use of moderate to high-intensity statin (MHIS) following myocardial perfusion imaging (MPI) results in fewer major adverse cardiovascular events (MACE) and is independently predictive of 24-month MACE among patients with normal stress MPI and coronary artery calcium (CAC) score >300, a Singapore study has shown.

P2Y12 inhibitor monotherapy on par with DAPT after complex PCI

Compared with standard dual antiplatelet therapy (DAPT), P2Y12 inhibitor monotherapy after 1- to 3-month DAPT results in similar rates of fatal and ischaemic events, as well as lower major bleeding risk, regardless of percutaneous coronary intervention (PCI) complexity, according to a study.